Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 1mg + Metformin (S.R.) I.P. 1000mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹209/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gimtype M1 Forte Tablet is a fixed-dose bi-layered formulation combining Glimepiride 1mg and Metformin 1000mg (Sustained Release). This dual-action oral antidiabetic medication supports comprehensive glycemic control in patients with type 2 diabetes. Glimepiride stimulates insulin release from pancreatic β-cells, while Metformin improves peripheral glucose uptake and reduces hepatic glucose production. The sustained-release mechanism of Metformin ensures prolonged blood sugar control with reduced gastrointestinal disturbances.
May cause hypoglycemia, nausea, stomach upset, dizziness, or mild weight gain. In rare cases, Metformin may cause lactic acidosis, especially in patients with kidney issues.
Indicated for the effective management of type 2 diabetes mellitus in adults, particularly in patients who require both enhanced insulin release and improved insulin sensitivity to maintain optimal glycemic levels.
Should be taken with meals to minimize gastrointestinal side effects. Regular monitoring of blood glucose and renal function is essential. Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is widely used in early and mild type 2 diabetes management, making it a consistent prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from steady demand in type 2 diabetes, early-stage blood sugar control, insulin resistance management, and long-term glycemic maintenance. It is commonly prescribed by physicians as a first-line combination therapy for better glucose control.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 1mg + Metformin Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.